HomeNewsTrendsCoronavirus pandemic | Centre may allow export of masks as manufacturers complain of unsold reserves

Coronavirus pandemic | Centre may allow export of masks as manufacturers complain of unsold reserves

The government is not willing to make any decision in haste as it is likely that demand will spike in the days to come with the gradual opening of the domestic market

May 26, 2020 / 18:36 IST
Story continues below Advertisement
Representative image
Representative image

The Centre is looking at allowing the export of certain type of face masks once India starts producing them in surplus capacity. Government sources have informed that a final call will be taken on this in the next few days.

The move comes amid requests from indigenous mask manufacturers to allow the export of surplus produce, reported Business Standard.

Story continues below Advertisement

After banning the export of masks of all kinds starting March, the director-general of foreign trade allowed export of non-surgical category masks from mid-May.

For live updates on coronavirus, click here

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show